tradingkey.logo
搜索

波士顿科学

BSX
添加自选
53.370USD
-0.560-1.04%
收盘 05/11, 16:00美东报价延迟15分钟
79.32B总市值
22.20市盈率 TTM

波士顿科学

53.370
-0.560-1.04%

关于 波士顿科学 公司

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

波士顿科学简介

公司代码BSX
公司名称Boston Scientific Corp
上市日期May 19, 1992
CEOMahoney (Michael F)
员工数量53000
证券类型Ordinary Share
年结日May 19
公司地址300 Boston Scientific Way
城市MARLBOROUGH
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编01752-1234
电话15086834000
网址https://www.bostonscientific.com/en-US/Home.html
公司代码BSX
上市日期May 19, 1992
CEOMahoney (Michael F)

波士顿科学公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
--
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
--

收入明细

单位: USD更新时间: 4月2日 周四
单位: USD更新时间: 4月2日 周四
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
其他
4.15B
20.69%
地区USD
名称
营收
占比
United States
12.86B
64.08%
EMEA (Europe, Middle East and Africa)
3.45B
17.19%
Asia Pacific
3.08B
15.34%
Latin America and Canada
678.00M
3.38%
业务
地区
业务USD
名称
营收
占比
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
其他
4.15B
20.69%

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Vanguard Capital Management, LLC
6.49%
Fidelity Management & Research Company LLC
5.85%
BlackRock Institutional Trust Company, N.A.
5.40%
State Street Investment Management (US)
4.43%
Geode Capital Management, L.L.C.
2.18%
其他
75.65%
持股股东
持股股东
占比
Vanguard Capital Management, LLC
6.49%
Fidelity Management & Research Company LLC
5.85%
BlackRock Institutional Trust Company, N.A.
5.40%
State Street Investment Management (US)
4.43%
Geode Capital Management, L.L.C.
2.18%
其他
75.65%
股东类型
持股股东
占比
Investment Advisor
51.84%
Investment Advisor/Hedge Fund
26.29%
Hedge Fund
6.11%
Pension Fund
3.03%
Research Firm
2.82%
Bank and Trust
2.02%
Sovereign Wealth Fund
1.83%
Private Equity
0.23%
Individual Investor
0.19%
其他
5.65%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
3113
1.40B
94.35%
-15.51M
2025Q4
2858
1.40B
94.34%
-402.85K
2025Q3
2905
1.40B
94.56%
+9.92M
2025Q2
2818
1.39B
94.08%
+7.87M
2025Q1
2724
1.38B
93.98%
-8.23M
2024Q4
2559
1.38B
93.68%
+12.79M
2024Q3
2401
1.36B
94.13%
-3.01M
2024Q2
2325
1.37B
94.20%
+2.64M
2024Q1
2212
1.37B
95.15%
-32.63M
2023Q4
2153
1.38B
96.34%
-8.17M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
86.99M
5.85%
-3.63M
-4.01%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
80.23M
5.4%
+634.35K
+0.80%
Dec 31, 2025
State Street Investment Management (US)
65.85M
4.43%
+920.50K
+1.42%
Dec 31, 2025
Geode Capital Management, L.L.C.
32.38M
2.18%
-306.76K
-0.94%
Dec 31, 2025
PRIMECAP Management Company
31.10M
2.09%
-2.01M
-6.06%
Dec 31, 2025
Capital World Investors
27.15M
1.83%
+502.63K
+1.89%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
23.07M
1.55%
+3.61M
+18.55%
Dec 31, 2025
The Bollard Group, LLC
19.00M
1.28%
-733.10K
-3.72%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月1日 周一
更新时间: 12月1日 周一
机构名称
占比
iShares U.S. Medical Devices ETF
12.15%
Goldman Sachs Future Health Care Equity ETF
8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
3.87%
Tema Heart & Health ETF
3.66%
First Trust Bloomberg R&D Leaders ETF
3.14%
Parnassus Core Select ETF
3.1%
WisdomTree US AI Enhanced Value Fund
3.1%
Health Care Select Sector SPDR Fund
3.06%
Global X Aging Population ETF
2.99%
Proshares Ultra Health Care
2.95%
查看更多
iShares U.S. Medical Devices ETF
占比12.15%
Goldman Sachs Future Health Care Equity ETF
占比8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
占比3.87%
Tema Heart & Health ETF
占比3.66%
First Trust Bloomberg R&D Leaders ETF
占比3.14%
Parnassus Core Select ETF
占比3.1%
WisdomTree US AI Enhanced Value Fund
占比3.1%
Health Care Select Sector SPDR Fund
占比3.06%
Global X Aging Population ETF
占比2.99%
Proshares Ultra Health Care
占比2.95%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI